Welcome to Medsafe

Medsafe is the New Zealand Medicines and Medical Devices Safety Authority. We are responsible for the regulation of medicines and medical devices in New Zealand. We ensure that medicines and medical devices are acceptably safe.

News and Events

Date Type Title
14 August 2018 Monitoring Communication M² Logo Isotretinoin and Obsessive Compulsive Disorder (OCD)
13 August 2018 Alert Communication Codeine – new restrictions on use in children and young adults
13 August 2018 Dear Healthcare Professional Letter Bicillin (PDF 1,135 KB, 4 Pages) -  Changes to expression of product strength
9 August 2018 Committees Medicines Adverse Reactions Committee - Vacancies
9 August 2018 Committees Medicines Classification Committee - Dates and Deadlines
9 August 2018 Committees Medicines Classification Committee - Agenda for the 61st meeting
8 August 2018 Committees A valid objection has been received regarding the following recommendation Modified-release paracetamol – proposed reclassification from pharmacy-only medicine to restricted medicine
7 August 2018 Surgical Mesh Adverse Event Reports relating to Surgical Mesh Implants dated August 2018 (PDF 16 pages, 294KB)
7 August 2018 Surgical Mesh All the surgical mesh information has been moved to a new surgical mesh area with a new Landing Page
6 August 2018 Monitoring Communication Dolutegravir and the possible risk of neural tube defects when taken early in pregnancy
27 July 2018 Medicine Consumer Level Recall - Melatonin 3mg tablets
25 July 2018 Consumer Information Leaflets Taking metformin for gestational diabetes (Te Reo version) (PDF 236 KB, 2 pages)
Taking metformin for gestational diabetes (Samoan version) (PDF 243 KB, 2 pages)
24 July 2018 Committees Minutes of the 60th meeting of the Medicines Classification Committee - Secretary's Note has been added to item 6.3 on Influenza vaccine
19 July 2018 Dear Healthcare Professional Letter Dissolution profile of Dilantin® 30 mg and 100 mg capsules (New Formulation)
3 July 2018 Dear Healthcare Professional Letter Provisional Consent of Neulactil periciazine 2.5mg and 10mg tablets (Hong Kong stock) to cover temporary stock shortage (PDF 78 KB, 2 pages)